Brief: Acer Therapeutics Reports Q2 2022 Results
15/08/2022 21:39
Aug 15 (Reuters) - Acer Therapeutics Inc ACER.O :
* ACER THERAPEUTICS REPORTS Q2 2022 FINANCIAL RESULTS AND
PROVIDES
CORPORATE UPDATE
* Q2 LOSS PER SHARE $0.17
* QTRLY CASH AND CASH EQUIVALENTS WERE $14.5 MILLION
* QTRLY LOSS PER SHARE $0.17
Source text for Eikon: ID:nGNX7cGqDl
Further company coverage: ACER.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acer Therapeutics
See all newsBrief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31